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Introduction: The acute GVHD grading for the Center for
International Blood and Marrow Transplant Research
(CIBMTR) reporting is based on criteria published by
Przepiorka et al (Bone Marrow Transplant,1995;15:825).
While the CIBMTR’s FormsNet3SM application allows elec-
tronic data submission, data professionals still need to
manually assign organ stages and overall grade, and track
data over time. We report the design and validation of an
electronic grader tool to automate acute GVHD severity
scoring.
Methods: Tables from the Przepiorka et al and the Rowlings
et al (Br J Haematol 1997; 97: 855) papers were used to build
logic for the “Consensus” and the IBMTR grading schemata
respectively. This free tool, aGVHD Grader (agvhd.com), was
developed using HTML, CSS and JavaScript. We also
reviewed the acute GVHD data on the NMDP and CIBMTR
forms for 30 patients with severe acute GVHD and tested
data entry in a prototype database version of the aGVHD
Grader.
Results: The 30 randomly selected allo-BMT patients were
transplanted between 1999 and 2014 with median age of
116.1 y and average follow-up of 2.33 y. Maximal acute
GVHD overall grade on submitted forms was recorded as II
in 2 (6.6%), III in 13 (43.3%) and IV in 15 (50%) cases. On this
retrospective review, the maximal grade was concordant in
22 cases but was revised from IV to III in eight cases; these
eight cases were scored based on institutional practice of
assigning stage 4 lower GI as overall grade IV. Additional
cause for diarrhea and elevated bilirubin was considered in
22 (73%) cases and downstaging done in 18 of them.
CIBMTR forms do not record downstaging and we wereFigure 1unable to ﬁnd consistent documentation of downstaging
process in the scorer’s internal data records. Histologic
evidence of GVHD in stomach or duodenum was found in
19 out of 21 cases with upper GI endoscopy; 11 of these
were scored as upper GI involved and 10 as not involved,
clinically.
We entered clinical data and bilirubin values into the
aGVHD Grader which automatically assigned organ stage,
downstaged for additional cause, and derived maximal
Consensus overall grade and IBMTR severity score accurately
in 100% cases when compared with manual scores using the
published criteria. We also generated a sample one-screen
view of daily acute GVHD assessments using the prototype
database version of the Grader (Figure 1).
Conclusions: Acute GVHD is a clinical syndrome with
considerable within-grade heterogeneity with different
patterns of skin, liver or gut involvement. Data professionals
commonly face situations when there is ambiguity in scoring
and in judging GVHD severity. The software program re-
ported here automates the organ staging and grading of
acute GVHD and enables tracking change over time. This may
help with consistency in data capture and error reduction
and serve as a useful record for outcomes reporting and
clinical research.120
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Background: Time management and cost reduction is in
the forefront for many centers today. Centers need to save
time and money, while accurately reporting data to the
Center for International Bone Marrow Transplant Research
(CIBMTR). Our center has researched and taken steps to
address these issues. As a result, our process for.
